Orthodox and unorthodox clavulanate combinations against extended-spectrum β-lactamase producers
- 1 January 2008
- journal article
- review article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 14, 189-193
- https://doi.org/10.1111/j.1469-0691.2007.01858.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The β-lactamase threat in Enterobacteriaceae, Pseudomonas and AcinetobacterTrends in Microbiology, 2006
- Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East EnglandJournal of Antimicrobial Chemotherapy, 2006
- Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum- -lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolateJournal of Antimicrobial Chemotherapy, 2006
- A Nosocomial Outbreak ofEscherichia coliProducing CTX-M-15 and OXA-30β-LactamaseInfection Control & Hospital Epidemiology, 2006
- Extended-Spectrum β-Lactamases: a Clinical UpdateClinical Microbiology Reviews, 2005
- BSAC standardized disc susceptibility testing method (version 4)Journal of Antimicrobial Chemotherapy, 2005
- Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UKJournal of Antimicrobial Chemotherapy, 2004
- TEM- and SHV-derived extended-spectrum β-lactamases: relationship between selection, structure and functionJournal of Antimicrobial Chemotherapy, 1995
- Determinants of the activity of -lactamase inhibitor combinationsJournal of Antimicrobial Chemotherapy, 1993
- Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamasesAntimicrobial Agents and Chemotherapy, 1990